Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 2.4B | 2.3B | 2.4B | 2.5B |
Cost of revenue | 1.9B | 1.9B | 1.9B | — |
Gross profit | 441M | 423M | 477M | — |
Operating expense | ||||
Research & development | 71M | 94M | 47M | 68M |
Selling general and admin | 246M | 225M | 222M | 238M |
Other operating expenses | — | — | — | — |
Operating income | 124M | 104M | 208M | 265M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | — | — | — | — |
Pretax income | 78M | 28M | 162M | 201M |
Tax provision | 28M | 20M | 42M | 52M |
Net income | 50M | 8M | 120M | 149M |
Basic EPS | 0.3 | 0.2 | 1.4 | 1.9 |
Diluted EPS | 0.3 | 0.2 | 1.4 | 1.9 |
Basic average shares | 75.7M | 80M | 82.5M | 74.7M |
Diluted average shares | 76.0M | 80M | 83.1M | 75.1M |
EBITDA | 329M | 87M | 408M | 364M |
Net income from continuing op. | 50M | 8M | 120M | 149M |
Minority interests | -1M | 4M | -2M | -4M |
Preferred stock dividends | 0 | 16M | 0 | 5M |